101 related articles for article (PubMed ID: 19220809)
1. 14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia.
Mancini M; Veljkovic N; Corradi V; Zuffa E; Corrado P; Pagnotta E; Martinelli G; Barbieri E; Santucci MA
Traffic; 2009 Jun; 10(6):637-47. PubMed ID: 19220809
[TBL] [Abstract][Full Text] [Related]
2. mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein.
Mancini M; Corradi V; Petta S; Martinelli G; Barbieri E; Santucci MA
Leuk Res; 2010 May; 34(5):641-8. PubMed ID: 19643477
[TBL] [Abstract][Full Text] [Related]
3. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage.
Yoshida K; Yamaguchi T; Natsume T; Kufe D; Miki Y
Nat Cell Biol; 2005 Mar; 7(3):278-85. PubMed ID: 15696159
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells.
Mao X; Yu CR; Li WH; Li WX
Cell Res; 2008 Aug; 18(8):879-88. PubMed ID: 18663379
[TBL] [Abstract][Full Text] [Related]
5. [The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine].
Sun JR; Zhang XH; He ZW; Gu Y; Yu YZ; Fang YM; Lü QH; Dong QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2246-51. PubMed ID: 17064567
[TBL] [Abstract][Full Text] [Related]
6. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells.
Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF
Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053
[TBL] [Abstract][Full Text] [Related]
7. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
8. P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors.
Brusa G; Zuffa E; Mancini M; Benvenuti M; Calonghi N; Barbieri E; Santucci MA
Br J Haematol; 2006 Feb; 132(3):359-69. PubMed ID: 16409301
[TBL] [Abstract][Full Text] [Related]
9. MEK kinase 1 is essential for Bcr-Abl-induced STAT3 and self-renewal activity in embryonic stem cells.
Nakamura Y; Yujiri T; Nawata R; Tagami K; Tanizawa Y
Oncogene; 2005 Nov; 24(51):7592-8. PubMed ID: 16044153
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase.
Burgess GS; Williamson EA; Cripe LD; Litz-Jackson S; Bhatt JA; Stanley K; Stewart MJ; Kraft AS; Nakshatri H; Boswell HS
Blood; 1998 Oct; 92(7):2450-60. PubMed ID: 9746785
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.
Dorey K; Engen JR; Kretzschmar J; Wilm M; Neubauer G; Schindler T; Superti-Furga G
Oncogene; 2001 Dec; 20(56):8075-84. PubMed ID: 11781820
[TBL] [Abstract][Full Text] [Related]
12. JNK1/c-Jun and p38 alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2.
Chen KC; Chiou YL; Chang LS
J Cell Biochem; 2009 Oct; 108(3):612-20. PubMed ID: 19670268
[TBL] [Abstract][Full Text] [Related]
13. Stress and death: breaking up the c-Abl/14-3-3 complex in apoptosis.
Pendergast AM
Nat Cell Biol; 2005 Mar; 7(3):213-4. PubMed ID: 15738971
[No Abstract] [Full Text] [Related]
14. Optimization of methods for the detection of BCR-ABL activity in Philadelphia-positive cells.
Hamilton A; Alhashimi F; Myssina S; Jorgensen HG; Holyoake TL
Exp Hematol; 2009 Mar; 37(3):395-401. PubMed ID: 19135772
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
[TBL] [Abstract][Full Text] [Related]
16. Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1.
Yi SJ; Lee HT; Groffen J; Heisterkamp N
Int J Mol Med; 2008 Oct; 22(4):453-8. PubMed ID: 18813851
[TBL] [Abstract][Full Text] [Related]
17. 14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.
Mancini M; Leo E; Takemaru K; Campi V; Castagnetti F; Soverini S; De Benedittis C; Rosti G; Cavo M; Santucci MA; Martinelli G
PLoS One; 2015; 10(7):e0131074. PubMed ID: 26147002
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
19. CD40 and B-cell receptor signalling induce MAPK family members that can either induce or repress Bcl-6 expression.
Batlle A; Papadopoulou V; Gomes AR; Willimott S; Melo JV; Naresh K; Lam EW; Wagner SD
Mol Immunol; 2009 May; 46(8-9):1727-35. PubMed ID: 19268365
[TBL] [Abstract][Full Text] [Related]
20. Identification of B cell adaptor for PI3-kinase (BCAP) as an Abl interactor 1-regulated substrate of Abl kinases.
Maruoka M; Suzuki J; Kawata S; Yoshida K; Hirao N; Sato S; Goff SP; Takeya T; Tani K; Shishido T
FEBS Lett; 2005 Jun; 579(14):2986-90. PubMed ID: 15893754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
